Back
Product details:
CAS
1393477-72-9
Purity
95%
Selinexor is a first-in-class selective inhibitor of nuclear transport compound. It binds to and inhibits exportin-1 (XPO1). Selinexor is indicated in combination with bortezomib and dexamethasone for the treatment of multiple myeloma in adult patients who have received at least one prior therapy.
Properties
Name
Selinexor
Smiles
FC(F)(F)C=1C=C(C=C(C1)C(F)(F)F)C=2N=CN(/C=C\C(=O)NNC=3C=NC=CN3)N2
Targets
Please log in to see this information
SDS
KPT-330 | selinexor
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$82
2 mg
$84
5 mg
$89
10 mg
$115
15 mg
$156
20 mg
$195
25 mg
$214
30 mg
$236
35 mg
$255
40 mg
$276
45 mg
$297
50 mg
$336
75 mg
$502
100 mg
$POA
Quantity
1
Total amount
$ 89
KPT-330 | selinexor
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.